18-254 - The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury
Status: open
Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Treatment for Thermal Burns
Description
The specific aims of the study are to determine the overall treatment effect and safety of glutamine in burn patients. Clinical outcomes will be: mortality, time to discharge alive, incidence of acquired bacteremia due to Gram negative organisms, hospital mortality, duration of mechanical ventilation, ICU stay and hospital stay. The cost-effectiveness of glutamine administration will also be measured if the results show a decrease in length of care or a reduced incidence of acquired bacteremia due to Gram negative organisms with glutamine.
Sponsors
This trial is sponsored by Stratatech.Interested in Clinical Trial?
Contact the Clinical Trial Coordinator
If you have questions get in touch with this Clinical Trial’s Coordinator by phone at 251-471-7988 or by email at kbose@health.southalabama.edu.
Providers Associated With This Trial
Principle Investigator
![Andrew Bright]()
View ProfileAndrew C. Bright, D.O.Trauma/Emergency General/Burn Surgeon
Sub Investigators
![Lintner Alicia]()
View ProfileAlicia C. Lintner, CRNPNurse Practitioner
